Literature DB >> 31578509

New antibodies best ZMapp in Ebola trial.

.   

Abstract

Entities:  

Year:  2019        PMID： 31578509     DOI： 10.1038/s41587-019-0284-y

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Will plant-made biopharmaceuticals play a role in the fight against COVID-19?

Authors:  Sergio Rosales-Mendoza
Journal:  Expert Opin Biol Ther       Date:  2020-04-13       Impact factor: 4.388

Review 2.  Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae.

Authors:  Lorenzo Barolo; Raffaela M Abbriano; Audrey S Commault; Jestin George; Tim Kahlke; Michele Fabris; Matthew P Padula; Angelo Lopez; Peter J Ralph; Mathieu Pernice
Journal:  Cells       Date:  2020-03-05       Impact factor: 6.600

3.  Potent neutralizing monoclonal antibodies against Ebola virus isolated from vaccinated donors.

Authors:  Pengfei Fan; Xiangyang Chi; Guodong Liu; Guanying Zhang; Zhengshan Chen; Yujiao Liu; Ting Fang; Jianmin Li; Logan Banadyga; Shihua He; Changming Yu; Xiangguo Qiu; Wei Chen
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.